Amundi Abb Vie Inc. Transaction History

Amundi

$239 Billion
Q1 2024

A detailed history of Amundi transactions in Abb Vie Inc. stock. As of the latest transaction made, Amundi holds 6,301,723 shares of ABBV stock, worth $1.08 Billion. This represents 0.48% of its overall portfolio holdings.

Number of Shares

6,301,723

Previous 7,981,925 21.05%

Holding current value

$1.08 Billion

Previous $1.24 Billion 7.23%

% of portfolio

0.48%

Previous 0.56%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $269 Million - $306 Million	-1,680,202 Reduced 21.05%	6,301,723 $1.15 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $32.4 Million - $36.5 Million	-235,414 Reduced 2.86%	7,981,925 $1.24 Billion
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $112 Million - $130 Million	-838,371 Reduced 9.26%	8,217,339 $1.22 Billion
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $53.5 Million - $66.5 Million	403,503 Added 4.66%	9,055,710 $1.22 Billion
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $361 Million - $415 Million	2,494,894 Added 40.52%	8,652,207 $1.38 Billion

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $138 Million - $166 Million	997,983 Added 19.34%	6,157,313 $996 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $46.6 Million - $53.4 Million	-346,952 Reduced 6.3%	5,159,330 $739 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $108 Million - $137 Million	783,076 Added 16.58%	5,506,282 $828 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $66.8 Million - $82.9 Million	-506,127 Reduced 9.68%	4,723,206 $818 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $63.1 Million - $79.9 Million	-587,591 Reduced 10.1%	5,229,333 $698 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $132 Million - $149 Million	1,236,167 Added 26.99%	5,816,924 $627 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $482 Million - $537 Million	4,580,757 New	4,580,757 $516 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account